Annual report

Period2023-01-21 → 2024-01-20

Filed2024-04-17

StandardJapan GAAP

ConsolidatedYes

Data checks24 of 24 passed

Key figures · 148

Metric	Value	Period	Scope	Source row
Revenue	¥213.4bn	2023-01-21 → 2024-01-20	Cons.	Net sales
Revenue	¥160.1bn	2022-01-21 → 2023-01-20	Cons.	Net sales
Revenue	¥162.6bn	2021-01-21 → 2022-01-20^d	Cons.	Net sales (5-year summary)
Revenue	¥158.2bn	2020-01-21 → 2021-01-20^d	Cons.	Net sales (5-year summary)
Revenue	¥168.3bn	2019-01-21 → 2020-01-20^d	Cons.	Net sales (5-year summary)
Operating income	¥3.7bn	2023-01-21 → 2024-01-20	Cons.	Operating income
Operating income	¥707m	2022-01-21 → 2023-01-20	Cons.	Operating income
Ordinary income	¥3.1bn	2023-01-21 → 2024-01-20	Cons.	Ordinary income
Ordinary income	¥591m	2022-01-21 → 2023-01-20	Cons.	Ordinary income
Ordinary income	¥5.7bn	2021-01-21 → 2022-01-20^d	Cons.	Ordinary income loss (5-year summary)
Ordinary income	¥5.7bn	2020-01-21 → 2021-01-20^d	Cons.	Ordinary income loss (5-year summary)
Ordinary income	¥2.9bn	2019-01-21 → 2020-01-20^d	Cons.	Ordinary income loss (5-year summary)
Profit before tax	¥5.6bn	2023-01-21 → 2024-01-20	Cons.	Income before income taxes
Profit before tax	¥1.1bn	2022-01-21 → 2023-01-20	Cons.	Income before income taxes
Net income (owners)	¥4.4bn	2023-01-21 → 2024-01-20	Cons.	Profit loss attributable to owners of parent
Net income (owners)	−¥507m	2022-01-21 → 2023-01-20	Cons.	Profit loss attributable to owners of parent
Net income (owners)	¥4.0bn	2021-01-21 → 2022-01-20^d	Cons.	Profit loss attributable to owners of parent (5-year summary)
Net income (owners)	¥3.2bn	2020-01-21 → 2021-01-20^d	Cons.	Profit loss attributable to owners of parent (5-year summary)
Net income (owners)	¥1.8bn	2019-01-21 → 2020-01-20^d	Cons.	Profit loss attributable to owners of parent (5-year summary)
Net income	¥4.6bn	2023-01-21 → 2024-01-20	Cons.	Profit loss
Net income	−¥490m	2022-01-21 → 2023-01-20	Cons.	Profit loss
Total assets	¥177.6bn	at 2024-01-20	Cons.	Assets
Total assets	¥164.2bn	at 2023-01-20	Cons.	Assets
Total assets	¥159.0bn	at 2022-01-20^d	Cons.	Total assets (5-year summary)
Total assets	¥157.6bn	at 2021-01-20^d	Cons.	Total assets (5-year summary)
Total assets	¥163.4bn	at 2020-01-20^d	Cons.	Total assets (5-year summary)
Total liabilities	¥86.1bn	at 2024-01-20	Cons.	Liabilities
Total liabilities	¥80.1bn	at 2023-01-20	Cons.	Liabilities
Net assets / equity	¥91.5bn	at 2024-01-20	Cons.	Net assets
Net assets / equity	¥84.1bn	at 2023-01-20	Cons.	Net assets
Net assets / equity	¥83.3bn	at 2022-01-20^d	Cons.	Net assets
Net assets / equity	¥82.6bn	at 2021-01-20^d	Cons.	Net assets (5-year summary)
Net assets / equity	¥89.2bn	at 2020-01-20^d	Cons.	Net assets (5-year summary)
Cash and deposits	¥32.4bn	at 2024-01-20	Cons.	Cash and deposits
Cash and deposits	¥27.2bn	at 2023-01-20	Cons.	Cash and deposits
Cash & equivalents	¥33.7bn	at 2024-01-20	Cons.	Cash and cash equivalents
Cash & equivalents	¥29.2bn	at 2023-01-20	Cons.	Cash and cash equivalents
Cash & equivalents	¥30.1bn	at 2022-01-20^d	Cons.	Cash and cash equivalents
Cash & equivalents	¥32.7bn	at 2021-01-20^d	Cons.	Cash and cash equivalents (5-year summary)
Cash & equivalents	¥30.3bn	at 2020-01-20^d	Cons.	Cash and cash equivalents (5-year summary)
Operating cash flow	¥9.2bn	2023-01-21 → 2024-01-20	Cons.	Net cash provided by used in operating activities
Operating cash flow	¥5.1bn	2022-01-21 → 2023-01-20	Cons.	Net cash provided by used in operating activities
Operating cash flow	¥8.1bn	2021-01-21 → 2022-01-20^d	Cons.	Net cash provided by used in operating activities (5-year summary)
Operating cash flow	¥12.5bn	2020-01-21 → 2021-01-20^d	Cons.	Net cash provided by used in operating activities (5-year summary)
Operating cash flow	¥11.5bn	2019-01-21 → 2020-01-20^d	Cons.	Net cash provided by used in operating activities (5-year summary)
Investing cash flow	−¥1.2bn	2023-01-21 → 2024-01-20	Cons.	Net cash provided by used in investment activities
Investing cash flow	−¥5.0bn	2022-01-21 → 2023-01-20	Cons.	Net cash provided by used in investment activities
Investing cash flow	−¥6.5bn	2021-01-21 → 2022-01-20^d	Cons.	Net cash provided by used in investing activities (5-year summary)
Investing cash flow	−¥7.6bn	2020-01-21 → 2021-01-20^d	Cons.	Net cash provided by used in investing activities (5-year summary)
Investing cash flow	−¥15.5bn	2019-01-21 → 2020-01-20^d	Cons.	Net cash provided by used in investing activities (5-year summary)
Financing cash flow	−¥3.2bn	2023-01-21 → 2024-01-20	Cons.	Net cash provided by used in financing activities
Financing cash flow	−¥1.1bn	2022-01-21 → 2023-01-20	Cons.	Net cash provided by used in financing activities
Financing cash flow	−¥3.7bn	2021-01-21 → 2022-01-20^d	Cons.	Net cash provided by used in financing activities (5-year summary)
Financing cash flow	−¥2.3bn	2020-01-21 → 2021-01-20^d	Cons.	Net cash provided by used in financing activities (5-year summary)
Financing cash flow	−¥4.1bn	2019-01-21 → 2020-01-20^d	Cons.	Net cash provided by used in financing activities (5-year summary)
EPS (basic)	¥140.77	2023-01-21 → 2024-01-20	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥-16.2	2022-01-21 → 2023-01-20	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥127.1	2021-01-21 → 2022-01-20^d	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥100.66	2020-01-21 → 2021-01-20^d	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥54	2019-01-21 → 2020-01-20^d	Cons.	Basic earnings loss per share (5-year summary)
Net assets per share	¥2,843.99	at 2024-01-20	Cons.	Net assets per share (5-year summary)
Net assets per share	¥2,663.79	at 2023-01-20	Cons.	Net assets per share (5-year summary)
Net assets per share	¥2,645.36	at 2022-01-20^d	Cons.	Net assets per share (5-year summary)
Net assets per share	¥2,612.23	at 2021-01-20^d	Cons.	Net assets per share (5-year summary)
Net assets per share	¥2,670.68	at 2020-01-20^d	Cons.	Net assets per share (5-year summary)
Equity ratio	50.4%	at 2024-01-20	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	50.9%	at 2023-01-20	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	52.1%	at 2022-01-20^d	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	51.8%	at 2021-01-20^d	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	53.9%	at 2020-01-20^d	Cons.	Equity to asset ratio (5-year summary)
ROE	5.1%	2023-01-21 → 2024-01-20	Cons.	Rate of return on equity (5-year summary)
ROE	-0.6%	2022-01-21 → 2023-01-20	Cons.	Rate of return on equity (5-year summary)
ROE	4.8%	2021-01-21 → 2022-01-20^d	Cons.	Rate of return on equity (5-year summary)
ROE	3.8%	2020-01-21 → 2021-01-20^d	Cons.	Rate of return on equity (5-year summary)
ROE	2.0%	2019-01-21 → 2020-01-20^d	Cons.	Rate of return on equity (5-year summary)
Employees	5,182	at 2024-01-20	Cons.	Number of employees
Employees	4,122	at 2023-01-20	Cons.	Number of employees
Employees	4,029	at 2022-01-20^d	Cons.	Number of employees
Employees	3,922	at 2021-01-20^d	Cons.	Number of employees
Employees	4,160	at 2020-01-20^d	Cons.	Number of employees
Revenue	¥5.3bn	2023-01-21 → 2024-01-20	Standalone	Operating revenue1
Revenue	¥5.0bn	2022-01-21 → 2023-01-20	Standalone	Operating revenue1
Revenue	¥4.8bn	2021-01-21 → 2022-01-20^d	Standalone	Operating revenue1 (5-year summary)
Revenue	¥4.8bn	2020-01-21 → 2021-01-20^d	Standalone	Operating revenue1 (5-year summary)
Revenue	¥6.6bn	2019-01-21 → 2020-01-20^d	Standalone	Operating revenue1 (5-year summary)
Operating income	¥1.1bn	2023-01-21 → 2024-01-20	Standalone	Operating income
Operating income	¥1.7bn	2022-01-21 → 2023-01-20	Standalone	Operating income
Ordinary income	¥2.0bn	2023-01-21 → 2024-01-20	Standalone	Ordinary income
Ordinary income	¥2.3bn	2022-01-21 → 2023-01-20	Standalone	Ordinary income
Ordinary income	¥2.4bn	2021-01-21 → 2022-01-20^d	Standalone	Ordinary income loss (5-year summary)
Ordinary income	¥1.9bn	2020-01-21 → 2021-01-20^d	Standalone	Ordinary income loss (5-year summary)
Ordinary income	¥4.0bn	2019-01-21 → 2020-01-20^d	Standalone	Ordinary income loss (5-year summary)
Profit before tax	¥4.0bn	2023-01-21 → 2024-01-20	Standalone	Income before income taxes
Profit before tax	¥2.8bn	2022-01-21 → 2023-01-20	Standalone	Income before income taxes
Net income	¥2.9bn	2023-01-21 → 2024-01-20	Standalone	Profit loss
Net income	¥1.9bn	2022-01-21 → 2023-01-20	Standalone	Profit loss
Net income	¥1.4bn	2021-01-21 → 2022-01-20^d	Standalone	Net income loss (5-year summary)
Net income	¥899m	2020-01-21 → 2021-01-20^d	Standalone	Net income loss (5-year summary)
Net income	¥2.4bn	2019-01-21 → 2020-01-20^d	Standalone	Net income loss (5-year summary)
Total assets	¥124.8bn	at 2024-01-20	Standalone	Assets
Total assets	¥122.7bn	at 2023-01-20	Standalone	Assets
Total assets	¥122.2bn	at 2022-01-20^d	Standalone	Total assets (5-year summary)
Total assets	¥116.8bn	at 2021-01-20^d	Standalone	Total assets (5-year summary)
Total assets	¥119.1bn	at 2020-01-20^d	Standalone	Total assets (5-year summary)
Total liabilities	¥42.4bn	at 2024-01-20	Standalone	Liabilities
Total liabilities	¥42.3bn	at 2023-01-20	Standalone	Liabilities
Net assets / equity	¥82.4bn	at 2024-01-20	Standalone	Net assets
Net assets / equity	¥80.5bn	at 2023-01-20	Standalone	Net assets
Net assets / equity	¥80.1bn	at 2022-01-20^d	Standalone	Net assets
Net assets / equity	¥78.5bn	at 2021-01-20^d	Standalone	Net assets (5-year summary)
Net assets / equity	¥84.7bn	at 2020-01-20^d	Standalone	Net assets (5-year summary)
Cash and deposits	¥25.8bn	at 2024-01-20	Standalone	Cash and deposits
Cash and deposits	¥21.1bn	at 2023-01-20	Standalone	Cash and deposits
EPS (basic)	¥92.22	2023-01-21 → 2024-01-20	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥61.07	2022-01-21 → 2023-01-20	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥45.88	2021-01-21 → 2022-01-20^d	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥28.25	2020-01-21 → 2021-01-20^d	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥73.96	2019-01-21 → 2020-01-20^d	Standalone	Basic earnings loss per share (5-year summary)
Dividend per share	¥60	2023-01-21 → 2024-01-20	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥60	2022-01-21 → 2023-01-20	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥60	2021-01-21 → 2022-01-20^d	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥60	2020-01-21 → 2021-01-20^d	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥60	2019-01-21 → 2020-01-20^d	Standalone	Dividend paid per share (5-year summary)
Net assets per share	¥2,618.07	at 2024-01-20	Standalone	Net assets per share (5-year summary)
Net assets per share	¥2,564.03	at 2023-01-20	Standalone	Net assets per share (5-year summary)
Net assets per share	¥2,559.09	at 2022-01-20^d	Standalone	Net assets per share (5-year summary)
Net assets per share	¥2,512.97	at 2021-01-20^d	Standalone	Net assets per share (5-year summary)
Net assets per share	¥2,570.8	at 2020-01-20^d	Standalone	Net assets per share (5-year summary)
Equity ratio	66.0%	at 2024-01-20	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	65.6%	at 2023-01-20	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	65.6%	at 2022-01-20^d	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	67.2%	at 2021-01-20^d	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	71.1%	at 2020-01-20^d	Standalone	Equity to asset ratio (5-year summary)
ROE	3.6%	2023-01-21 → 2024-01-20	Standalone	Rate of return on equity (5-year summary)
ROE	2.4%	2022-01-21 → 2023-01-20	Standalone	Rate of return on equity (5-year summary)
ROE	1.8%	2021-01-21 → 2022-01-20^d	Standalone	Rate of return on equity (5-year summary)
ROE	1.1%	2020-01-21 → 2021-01-20^d	Standalone	Rate of return on equity (5-year summary)
ROE	2.8%	2019-01-21 → 2020-01-20^d	Standalone	Rate of return on equity (5-year summary)
Shares issued	16,568,000	at 2024-01-20	Standalone	Total number of issued shares (5-year summary)
Shares issued	16,568,000	at 2023-01-20	Standalone	Total number of issued shares (5-year summary)
Shares issued	16,568,000	at 2022-01-20^d	Standalone	Total number of issued shares (5-year summary)
Shares issued	16,568,000	at 2021-01-20^d	Standalone	Total number of issued shares (5-year summary)
Shares issued	16,568,000	at 2020-01-20^d	Standalone	Total number of issued shares (5-year summary)
Employees	39	at 2024-01-20	Standalone	Number of employees
Employees	26	at 2023-01-20	Standalone	Number of employees
Employees	23	at 2022-01-20^d	Standalone	Number of employees
Employees	19	at 2021-01-20^d	Standalone	Number of employees
Employees	21	at 2020-01-20^d	Standalone	Number of employees

Periods use the dates stated in the filing. ^d = earlier-year period dated by calendar; ^v = that date confirmed by the company's own earlier filing.

Segments · 93

Segment	Item	Period	Value
Reconciling Itemsreconciling	capex	2023-01-21 → 2024-01-20	¥926m
Reconciling Itemsreconciling	depreciation	2023-01-21 → 2024-01-20	¥793m
Reconciling Itemsreconciling	revenue	2023-01-21 → 2024-01-20	−¥366m
Reconciling Itemsreconciling	revenue intersegment	2023-01-21 → 2024-01-20	−¥366m
Reconciling Itemsreconciling	segment assets	at 2024-01-20	¥44.8bn
Reconciling Itemsreconciling	segment profit	2023-01-21 → 2024-01-20	−¥2.2bn
Domestic Beverage Businessreportable segment	capex	2023-01-21 → 2024-01-20	¥9.4bn
Domestic Beverage Businessreportable segment	depreciation	2023-01-21 → 2024-01-20	¥5.1bn
Domestic Beverage Businessreportable segment	employees	at 2024-01-20	3776 pure
Domestic Beverage Businessreportable segment	revenue	2023-01-21 → 2024-01-20	¥153.6bn
Domestic Beverage Businessreportable segment	revenue external	2023-01-21 → 2024-01-20	¥153.6bn
Domestic Beverage Businessreportable segment	revenue intersegment	2023-01-21 → 2024-01-20	¥26m
Domestic Beverage Businessreportable segment	segment assets	at 2024-01-20	¥74.7bn
Domestic Beverage Businessreportable segment	segment profit	2023-01-21 → 2024-01-20	¥4.3bn
Dy Do Pharmareportable segment	capex	2023-01-21 → 2024-01-20	¥57m
Dy Do Pharmareportable segment	depreciation	2023-01-21 → 2024-01-20	¥9m
Dy Do Pharmareportable segment	employees	at 2024-01-20	14 pure
Dy Do Pharmareportable segment	segment assets	at 2024-01-20	¥381m
Dy Do Pharmareportable segment	segment profit	2023-01-21 → 2024-01-20	−¥796m
Food Businessreportable segment	capex	2023-01-21 → 2024-01-20	¥638m
Food Businessreportable segment	depreciation	2023-01-21 → 2024-01-20	¥848m
Food Businessreportable segment	employees	at 2024-01-20	272 pure
Food Businessreportable segment	revenue	2023-01-21 → 2024-01-20	¥20.7bn
Food Businessreportable segment	revenue external	2023-01-21 → 2024-01-20	¥20.7bn
Food Businessreportable segment	revenue intersegment	2023-01-21 → 2024-01-20	¥7m
Food Businessreportable segment	segment assets	at 2024-01-20	¥21.4bn
Food Businessreportable segment	segment profit	2023-01-21 → 2024-01-20	¥993m
International Beverage Businessreportable segment	capex	2023-01-21 → 2024-01-20	¥1.2bn
International Beverage Businessreportable segment	depreciation	2023-01-21 → 2024-01-20	¥859m
International Beverage Businessreportable segment	employees	at 2024-01-20	749 pure
International Beverage Businessreportable segment	revenue	2023-01-21 → 2024-01-20	¥26.4bn
International Beverage Businessreportable segment	revenue external	2023-01-21 → 2024-01-20	¥26.4bn
International Beverage Businessreportable segment	segment assets	at 2024-01-20	¥16.7bn
International Beverage Businessreportable segment	segment profit	2023-01-21 → 2024-01-20	¥1.1bn
Pharmaceutical Related Businessreportable segment	capex	2023-01-21 → 2024-01-20	¥483m
Pharmaceutical Related Businessreportable segment	depreciation	2023-01-21 → 2024-01-20	¥1.2bn
Pharmaceutical Related Businessreportable segment	employees	at 2024-01-20	332 pure
Pharmaceutical Related Businessreportable segment	revenue	2023-01-21 → 2024-01-20	¥13.0bn
Pharmaceutical Related Businessreportable segment	revenue external	2023-01-21 → 2024-01-20	¥12.6bn
Pharmaceutical Related Businessreportable segment	revenue intersegment	2023-01-21 → 2024-01-20	¥331m
Pharmaceutical Related Businessreportable segment	segment assets	at 2024-01-20	¥19.5bn
Pharmaceutical Related Businessreportable segment	segment profit	2023-01-21 → 2024-01-20	¥367m
—segment total	capex	2023-01-21 → 2024-01-20	¥11.7bn
—segment total	depreciation	2023-01-21 → 2024-01-20	¥8.0bn
—segment total	revenue	2023-01-21 → 2024-01-20	¥213.7bn
—segment total	revenue external	2023-01-21 → 2024-01-20	¥213.4bn
—segment total	revenue intersegment	2023-01-21 → 2024-01-20	¥366m
—segment total	segment assets	at 2024-01-20	¥132.7bn
—segment total	segment profit	2023-01-21 → 2024-01-20	¥5.9bn
Reconciling Itemsreconciling	capex	2022-01-21 → 2023-01-20	¥1.5bn
Reconciling Itemsreconciling	depreciation	2022-01-21 → 2023-01-20	¥373m
Reconciling Itemsreconciling	revenue	2022-01-21 → 2023-01-20	−¥636m
Reconciling Itemsreconciling	revenue intersegment	2022-01-21 → 2023-01-20	−¥636m
Reconciling Itemsreconciling	segment assets	at 2023-01-20	¥47.8bn
Reconciling Itemsreconciling	segment profit	2022-01-21 → 2023-01-20	−¥1.6bn
Domestic Beverage Businessreportable segment	capex	2022-01-21 → 2023-01-20	¥8.3bn
Domestic Beverage Businessreportable segment	depreciation	2022-01-21 → 2023-01-20	¥4.6bn
Domestic Beverage Businessreportable segment	revenue	2022-01-21 → 2023-01-20	¥109.8bn
Domestic Beverage Businessreportable segment	revenue external	2022-01-21 → 2023-01-20	¥109.7bn
Domestic Beverage Businessreportable segment	revenue intersegment	2022-01-21 → 2023-01-20	¥25m
Domestic Beverage Businessreportable segment	segment assets	at 2023-01-20	¥60.4bn
Domestic Beverage Businessreportable segment	segment profit	2022-01-21 → 2023-01-20	¥2.8bn
Dy Do Pharmareportable segment	capex	2022-01-21 → 2023-01-20	¥1m
Dy Do Pharmareportable segment	depreciation	2022-01-21 → 2023-01-20	¥2m
Dy Do Pharmareportable segment	segment assets	at 2023-01-20	¥1.1bn
Dy Do Pharmareportable segment	segment profit	2022-01-21 → 2023-01-20	−¥499m
Food Businessreportable segment	capex	2022-01-21 → 2023-01-20	¥877m
Food Businessreportable segment	depreciation	2022-01-21 → 2023-01-20	¥848m
Food Businessreportable segment	revenue	2022-01-21 → 2023-01-20	¥19.6bn
Food Businessreportable segment	revenue external	2022-01-21 → 2023-01-20	¥19.6bn
Food Businessreportable segment	revenue intersegment	2022-01-21 → 2023-01-20	¥8m
Food Businessreportable segment	segment assets	at 2023-01-20	¥21.8bn
Food Businessreportable segment	segment profit	2022-01-21 → 2023-01-20	¥765m
International Beverage Businessreportable segment	capex	2022-01-21 → 2023-01-20	¥522m
International Beverage Businessreportable segment	depreciation	2022-01-21 → 2023-01-20	¥718m
International Beverage Businessreportable segment	revenue	2022-01-21 → 2023-01-20	¥18.9bn
International Beverage Businessreportable segment	revenue external	2022-01-21 → 2023-01-20	¥18.9bn
International Beverage Businessreportable segment	segment assets	at 2023-01-20	¥13.5bn
International Beverage Businessreportable segment	segment profit	2022-01-21 → 2023-01-20	−¥1.1bn
Pharmaceutical Related Businessreportable segment	capex	2022-01-21 → 2023-01-20	¥220m
Pharmaceutical Related Businessreportable segment	depreciation	2022-01-21 → 2023-01-20	¥1.2bn
Pharmaceutical Related Businessreportable segment	revenue	2022-01-21 → 2023-01-20	¥12.5bn
Pharmaceutical Related Businessreportable segment	revenue external	2022-01-21 → 2023-01-20	¥11.9bn
Pharmaceutical Related Businessreportable segment	revenue intersegment	2022-01-21 → 2023-01-20	¥601m
Pharmaceutical Related Businessreportable segment	segment assets	at 2023-01-20	¥19.7bn
Pharmaceutical Related Businessreportable segment	segment profit	2022-01-21 → 2023-01-20	¥347m
—segment total	capex	2022-01-21 → 2023-01-20	¥9.9bn
—segment total	depreciation	2022-01-21 → 2023-01-20	¥7.4bn
—segment total	revenue	2022-01-21 → 2023-01-20	¥160.8bn
—segment total	revenue external	2022-01-21 → 2023-01-20	¥160.1bn
—segment total	revenue intersegment	2022-01-21 → 2023-01-20	¥636m
—segment total	segment assets	at 2023-01-20	¥116.4bn
—segment total	segment profit	2022-01-21 → 2023-01-20	¥2.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,755

Item	Context	Value	Unit
Liabilities	Prior1YearInstant_NonConsolidatedMember	42279000000	JPY
Liabilities	CurrentYearInstant_NonConsolidatedMember	42388000000	JPY
Capital stock	Prior1YearInstant_NonConsolidatedMember	1924000000	JPY
Capital stock	CurrentYearInstant_NonConsolidatedMember	1924000000	JPY
Legal capital surplus	Prior1YearInstant_NonConsolidatedMember	1464000000	JPY
Legal capital surplus	CurrentYearInstant_NonConsolidatedMember	1464000000	JPY
Other capital surplus	Prior1YearInstant_NonConsolidatedMember	－	JPY
Other capital surplus	CurrentYearInstant_NonConsolidatedMember	14000000	JPY
Capital surplus	Prior1YearInstant_NonConsolidatedMember	1464000000	JPY
Capital surplus	CurrentYearInstant_NonConsolidatedMember	1478000000	JPY
Legal retained earnings	Prior1YearInstant_NonConsolidatedMember	137000000	JPY
Legal retained earnings	CurrentYearInstant_NonConsolidatedMember	137000000	JPY
General reserve	Prior1YearInstant_NonConsolidatedMember	55650000000	JPY
General reserve	CurrentYearInstant_NonConsolidatedMember	55650000000	JPY
Contribution reserve for local community ore	Prior1YearInstant_NonConsolidatedMember	243000000	JPY
Contribution reserve for local community ore	CurrentYearInstant_NonConsolidatedMember	179000000	JPY
Retained earnings brought forward	Prior1YearInstant_NonConsolidatedMember	21143000000	JPY
Retained earnings brought forward	CurrentYearInstant_NonConsolidatedMember	23151000000	JPY
Retained earnings	Prior1YearInstant_NonConsolidatedMember	77174000000	JPY
Retained earnings	CurrentYearInstant_NonConsolidatedMember	79118000000	JPY
Treasury stock	Prior1YearInstant_NonConsolidatedMember	-4047000000	JPY
Treasury stock	CurrentYearInstant_NonConsolidatedMember	-3796000000	JPY
Shareholders equity	Prior1YearInstant_NonConsolidatedMember	76515000000	JPY
Shareholders equity	CurrentYearInstant_NonConsolidatedMember	78724000000	JPY
Valuation difference on available for sale securities	Prior1YearInstant_NonConsolidatedMember	3948000000	JPY
Valuation difference on available for sale securities	CurrentYearInstant_NonConsolidatedMember	3633000000	JPY
Deferred gains or losses on hedges	Prior1YearInstant_NonConsolidatedMember	－	JPY
Deferred gains or losses on hedges	CurrentYearInstant_NonConsolidatedMember	77000000	JPY
Valuation and translation adjustments	Prior1YearInstant_NonConsolidatedMember	3948000000	JPY
Valuation and translation adjustments	CurrentYearInstant_NonConsolidatedMember	3710000000	JPY
Net assets	Prior1YearInstant_NonConsolidatedMember	80464000000	JPY
Net assets	CurrentYearInstant_NonConsolidatedMember	82435000000	JPY
Liabilities and net assets	Prior1YearInstant_NonConsolidatedMember	122743000000	JPY
Liabilities and net assets	CurrentYearInstant_NonConsolidatedMember	124824000000	JPY
Royalty income rev oa	Prior1YearDuration_NonConsolidatedMember	3111000000	JPY
Royalty income rev oa	CurrentYearDuration_NonConsolidatedMember	2573000000	JPY
Income from system use of subsidiaries rev oa	Prior1YearDuration_NonConsolidatedMember	1639000000	JPY
Income from system use of subsidiaries rev oa	CurrentYearDuration_NonConsolidatedMember	2052000000	JPY
Dividends from subsidiaries and affiliates rev oa	Prior1YearDuration_NonConsolidatedMember	231000000	JPY
Dividends from subsidiaries and affiliates rev oa	CurrentYearDuration_NonConsolidatedMember	664000000	JPY
Operating revenue1	Prior1YearDuration_NonConsolidatedMember	4982000000	JPY
Operating revenue1	CurrentYearDuration_NonConsolidatedMember	5290000000	JPY
Operating expenses	Prior1YearDuration_NonConsolidatedMember	3296000000	JPY
Operating expenses	CurrentYearDuration_NonConsolidatedMember	4211000000	JPY
Operating income	Prior1YearDuration_NonConsolidatedMember	1686000000	JPY
Operating income	CurrentYearDuration_NonConsolidatedMember	1078000000	JPY
Interest and dividends income noi	Prior1YearDuration_NonConsolidatedMember	575000000	JPY
Interest and dividends income noi	CurrentYearDuration_NonConsolidatedMember	431000000	JPY
Foreign exchange gains noi	Prior1YearDuration_NonConsolidatedMember	－	JPY
Foreign exchange gains noi	CurrentYearDuration_NonConsolidatedMember	447000000	JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed

balance sheet identity	consolidated 2023-01-20	pass
balance sheet identity	consolidated 2024-01-20	pass rounding
balance sheet identity	non_consolidated 2023-01-20	pass
balance sheet identity	non_consolidated 2024-01-20	pass rounding
dei present		pass
period resolution		pass
statement vs summary · net assets	consolidated 2022-01-20	pass
statement vs summary · net assets	consolidated 2023-01-20	pass
statement vs summary · net assets	consolidated 2024-01-20	pass
statement vs summary · net assets	non_consolidated 2022-01-20	pass
statement vs summary · net assets	non_consolidated 2023-01-20	pass
statement vs summary · net assets	non_consolidated 2024-01-20	pass
statement vs summary · net income attributable to parent	consolidated 2022-01-21/2023-01-20	pass
statement vs summary · net income attributable to parent	consolidated 2023-01-21/2024-01-20	pass
statement vs summary · operating cash flow	consolidated 2022-01-21/2023-01-20	pass
statement vs summary · operating cash flow	consolidated 2023-01-21/2024-01-20	pass
statement vs summary · revenue	consolidated 2022-01-21/2023-01-20	pass
statement vs summary · revenue	consolidated 2023-01-21/2024-01-20	pass
statement vs summary · revenue	non_consolidated 2022-01-21/2023-01-20	pass
statement vs summary · revenue	non_consolidated 2023-01-21/2024-01-20	pass
statement vs summary · total assets	consolidated 2023-01-20	pass
statement vs summary · total assets	consolidated 2024-01-20	pass
statement vs summary · total assets	non_consolidated 2023-01-20	pass
statement vs summary · total assets	non_consolidated 2024-01-20	pass